Announces Preclinical COVID-19 Research Tools RENSSELAER, N.Y., March 20, 2020 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces support for global COVID-19 research efforts via a new Coronavirus Toolkit featuring relevant models and services. Mouse models have been extensively used for research on the SARS-CoV virus, closely […]

Proven Model Available Exclusively From Taconic Biosciences RENSSELAER, N.Y., Nov. 04, 2019 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new  Alzheimer’s disease model, the ARTE10 mouse model. Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant […]

Dr. Frank Sistare Joins Taconic Biosciences’ Scientific Advisory Board RENSSELAER, N.Y., Oct. 17, 2019 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the addition of Frank Sistare, PhD to its Scientific Advisory Board (SAB).  Dr. Sistare joins existing SAB members Andrew Goodman, PhD, David Hill, PhD, and […]

RENSSELAER, N.Y., April 01, 2019 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces it has obtained a license to the Wild Mouse gut microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). Investigators at the […]